Related Experiment Videos
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient
R Bottlender1, M Jäger, E Hofschuster
1Department of Psychiatry, Ludwig-Maximilians-University, Munich. bottlend@psy.med.uni-muenchen.de
Abstract:
Neuroleptic malignant syndrome (NMS) is a rare, but potentially lethal complication of antipsychotic medication. The risk of developing NMS under atypical neuroleptics seems lower than under typical neuroleptics. However, the use of atypical neuroleptics in modern psychopharmacotherapy is increasing, so the incidence of NMS under these drugs may also increase. Here, we will describe three episodes of NMS that fulfilled the DSM-IV criteria for NMS (APA, 1994). The epivodes of NMS occured under treatment with clozapine, risperidone, and amisulpride. These episodes had some atypical features that will be discussed with regard to the pathophysiological mechanisms leading to NMS.
Insights
Neuroleptic malignant syndrome (NMS), a rare but serious antipsychotic side effect, may increase with rising atypical neuroleptic use. This study details three NMS cases with atypical features under clozapine, risperidone, and amisulpride.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Medicine
Background:
- Neuroleptic malignant syndrome (NMS) is a rare, life-threatening complication associated with antipsychotic medications.
- While atypical neuroleptics are generally considered to have a lower risk than typical neuroleptics, their increasing use necessitates ongoing surveillance.
- Understanding NMS pathophysiology is crucial for managing patients on modern psychopharmacotherapy.
Observation:
- This report describes three distinct episodes of NMS that met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria.
- The NMS episodes occurred during treatment with specific atypical antipsychotics: clozapine, risperidone, and amisulpride.
- These cases presented with several atypical features that warrant further investigation.
Findings:
- The observed NMS episodes, while fulfilling DSM-IV criteria, exhibited atypical characteristics.
- The specific atypical neuroleptics involved were clozapine, risperidone, and amisulpride.
- Analysis of these atypical features may provide new insights into NMS pathogenesis.
Implications:
- Increased vigilance for NMS is recommended, even with atypical antipsychotics.
- Further research into the pathophysiological mechanisms underlying atypical NMS presentations is needed.
- This study contributes to the understanding of rare but severe adverse drug reactions in psychopharmacology.